-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Coya Therapeutics (COYA)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Coya Therapeutics (COYA)
-
-
-
-
-
-
-
Coya Therapeutics reports positive preclinical results for COYA 303
-
-
-
-
-
-
-
Lake Street Capital Markets Starts Coya Therapeutics (COYA) at Buy
-
-
-
-
-
-
-
Coya Therapeutics (COYA) publicizes results of of COYA 303 study
-
-
-
-
-
-
-
Coya Therapeutics (COYA) Provides Enrollment Update of Phase 1 Study of Low Dose Interleukin-2 + CTLA4-Ig Fusion Protein
-
-
-
-
-
-
-
Coya Therapeutics (COYA) Announces Subcutaneously Administered COYA 302 Elicits Direct Anti-Inflammatory Effect in Brain in a Preclinical Inflammatory Mouse Model of Parkinson’s Disease
-
416,811 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

